Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study

Qian Xu, Jing-Jing Ni, Bai-Xue Han, Shan-Shan Yan, Xin-Tong Wei, Gui-Juan Feng, Hong Zhang, Lei Zhang, Bin Li, Yu-Fang Pei, Qian Xu, Jing-Jing Ni, Bai-Xue Han, Shan-Shan Yan, Xin-Tong Wei, Gui-Juan Feng, Hong Zhang, Lei Zhang, Bin Li, Yu-Fang Pei

Abstract

Background: Growing evidence has shown that alterations in gut microbiota composition are associated with multiple autoimmune diseases (ADs). However, it is unclear whether these associations reflect a causal relationship.

Objective: To reveal the causal association between gut microbiota and AD, we conducted a two-sample Mendelian randomization (MR) analysis.

Materials and methods: We assessed genome-wide association study (GWAS) summary statistics for gut microbiota and six common ADs, namely, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, type 1 diabetes (T1D), and celiac disease (CeD), from published GWASs. Two-sample MR analyses were first performed to identify causal bacterial taxa for ADs in discovery samples. Significant bacterial taxa were further replicated in independent replication outcome samples. A series of sensitivity analyses was performed to validate the robustness of the results. Finally, a reverse MR analysis was performed to evaluate the possibility of reverse causation.

Results: Combining the results from the discovery and replication stages, we identified one causal bacterial genus, Bifidobacterium. A higher relative abundance of the Bifidobacterium genus was associated with a higher risk of T1D [odds ratio (OR): 1.605; 95% CI, 1.339-1.922; PFDR = 4.19 × 10-7] and CeD (OR: 1.401; 95% CI, 1.139-1.722; PFDR = 2.03 × 10-3), respectively. Further sensitivity analyses validated the robustness of the above associations. The results of reverse MR analysis showed no evidence of reverse causality from T1D and CeD to the Bifidobacterium genus.

Conclusion: This study implied a causal relationship between the Bifidobacterium genus and T1D and CeD, thus providing novel insights into the gut microbiota-mediated development mechanism of ADs.

Keywords: Mendelian randomization; autoimmune disease (AD); celiac disease; gut microbiota; type 1 diabetes.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Xu, Ni, Han, Yan, Wei, Feng, Zhang, Zhang, Li and Pei.

Figures

Figure 1
Figure 1
The flowchart of the study. The whole workflow of MR analysis. MR, Mendelian randomization; SLE, systemic lupus erythematosus; RA, rheumatoid arthritis; MS, multiple sclerosis; IBD, inflammatory bowel disease; T1D, type 1 diabetes; CeD, celiac disease.
Figure 2
Figure 2
Leave-one-out analysis of the causal effect of Bifidobacterium on T1D. Red lines represent estimations from the IVW test. T1D, type 1 diabetes; IVW, inverse variance weighted.
Figure 3
Figure 3
Leave-one-out analysis of the causal effect of Bifidobacterium on CeD. Red lines represent estimations from the IVW test. CeD, celiac disease; IVW, inverse variance weighted.

References

    1. Lerner A, Jeremias P, Matthias T. The World Incidence and Prevalence of Autoimmune Diseases is Increasing. Int J Celiac Dis (2015) 3:151–5.
    1. De Luca F, Shoenfeld Y. The Microbiome in Autoimmune Diseases. Clin Exp Immunol (2019) 195:74–85. doi: 10.1111/cei.13158
    1. Chen B, Sun L, Zhang X. Integration of Microbiome and Epigenome to Decipher the Pathogenesis of Autoimmune Diseases. J Autoimmun (2017) 83:31–42. doi: 10.1016/j.jaut.2017.03.009
    1. López P, de Paz B, Rodríguez-Carrio J, Hevia A, Sánchez B, Margolles A, et al. . Th17 Responses and Natural IgM Antibodies are Related to Gut Microbiota Composition in Systemic Lupus Erythematosus Patients. Sci Rep (2016) 6:24072. doi: 10.1038/srep24072
    1. Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, et al. . Gut Microbiota in Children With Type 1 Diabetes Differs From That in Healthy Children: A Case-Control Study. BMC Med (2013) 11:46. doi: 10.1186/1741-7015-11-46
    1. Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, et al. . Alterations of the Human Gut Microbiome in Multiple Sclerosis. Nat Commun (2016) 7:12015. doi: 10.1038/ncomms12015
    1. Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. . An Expansion of Rare Lineage Intestinal Microbes Characterizes Rheumatoid Arthritis. Genome Med (2016) 8(1):43. doi: 10.1186/s13073-016-0299-7
    1. Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA (2017) 318(19):1925–6. doi: 10.1001/jama.2017.17219
    1. Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, et al. . Genetic Determinants of the Gut Microbiome in UK Twins. Cell Host Microbe (2016) 19(5):731–43. doi: 10.1016/j.chom.2016.04.017
    1. Wang J, Thingholm LB, Skiecevičienė J, Rausch P, Kummen M, Hov JR, et al. . Genome-Wide Association Analysis Identifies Variation in Vitamin D Receptor and Other Host Factors Influencing the Gut Microbiota. Nat Genet (2016) 48(11):1396–406. doi: 10.1038/ng.3695
    1. Bonder MJ, Kurilshikov A, Tigchelaar EF, Mujagic Z, Imhann F, Vila AV, et al. . The Effect of Host Genetics on the Gut Microbiome. Nat Genet (2016) 48(11):1407–12. doi: 10.1038/ng.3663
    1. García-Santisteban I, Cilleros-Portet A, Moyua-Ormazabal E, Kurilshikov A, Zhernakova A, Garcia-Etxebarria K, et al. . A Two-Sample Mendelian Randomization Analysis Investigates Associations Between Gut Microbiota and Celiac Disease. Nutrients (2020) 12(5):1420. doi: 10.3390/nu12051420
    1. Inamo J. Non-Causal Association of Gut Microbiome on the Risk of Rheumatoid Arthritis: A Mendelian Randomisation Study. Ann Rheum Dis (2021) 81(1):e3. doi: 10.1136/annrheumdis-2019-216565
    1. Zhang ZJ, Qu HL, Zhao N, Wang J, Wang XY, Hai R, et al. . Assessment of Causal Direction Between Gut Microbiota and Inflammatory Bowel Disease: A Mendelian Randomization Analysis. Front Genet (2021) 12:631061. doi: 10.3389/fgene.2021.631061
    1. Xiang K, Wang P, Xu Z, Hu YQ, He YS, Chen Y, et al. . Causal Effects of Gut Microbiome on Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study. Front Immunol (2021) 12:667097. doi: 10.3389/fimmu.2021.667097
    1. Kurilshikov A, Medina-Gomez C, Bacigalupe R, Radjabzadeh D, Wang J, Demirkan A, et al. . Large-Scale Association Analyses Identify Host Factors Influencing Human Gut Microbiome Composition. Nat Genet (2021) 53(2):156–65. doi: 10.1038/s41588-020-00763-1
    1. Bentham J, Morris DL, Graham DSC, Pinder CL, Tombleson P, Behrens TW, et al. . Genetic Association Analyses Implicate Aberrant Regulation of Innate and Adaptive Immunity Genes in the Pathogenesis of Systemic Lupus Erythematosus. Nat Genet (2015) 47(12):1457–64. doi: 10.1038/ng.3434
    1. Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, et al. . Genetics of Rheumatoid Arthritis Contributes to Biology and Drug Discovery. Nature (2014) 506(7488):376–81. doi: 10.1038/nature12873
    1. de Lange KM, Moutsianas L, Lee JC, Lamb CA, Luo Y, Kennedy NA, et al. . Genome-Wide Association Study Implicates Immune Activation of Multiple Integrin Genes in Inflammatory Bowel Disease. Nat Genet (2017) 49(2):256–61. doi: 10.1038/ng.3760
    1. International Multiple Sclerosis Genetics Consortium . Multiple Sclerosis Genomic Map Implicates Peripheral Immune Cells and Microglia in Susceptibility. Sci (New York NY) (2019) 365(6460):eaav7188. doi: 10.1126/science.aav7188
    1. Onengut-Gumuscu S, Chen WM, Burren O, Cooper NJ, Quinlan AR, Mychaleckyj JC, et al. . Fine Mapping of Type 1 Diabetes Susceptibility Loci and Evidence for Colocalization of Causal Variants With Lymphoid Gene Enhancers. Nat Genet (2015) 47(4):381–6. doi: 10.1038/ng.3245
    1. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, et al. . Dense Genotyping Identifies and Localizes Multiple Common and Rare Variant Association Signals in Celiac Disease. Nat Genet (2011) 43(12):1193–201. doi: 10.1038/ng.998
    1. Julià A, López-Longo FJ, Pérez Venegas JJ, Bonàs-Guarch S, Olivé À, Andreu JL, et al. . Genome-Wide Association Study Meta-Analysis Identifies Five New Loci for Systemic Lupus Erythematosus. Arthritis Res Ther (2018) 20(1):100. doi: 10.1186/s13075-018-1604-1
    1. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, et al. . Multiple Common Variants for Celiac Disease Influencing Immune Gene Expression. Nat Genet (2010) 42:295–302. doi: 10.1038/ng.543
    1. Verbanck M, Chen CY, Neale B, Do R. Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred From Mendelian Randomization Between Complex Traits and Diseases. Nat Genet (2018) 50(5):693–8. doi: 10.1038/s41588-018-0099-7
    1. Pierce BL, Ahsan H, Vanderweele TJ. Power and Instrument Strength Requirements for Mendelian Randomization Studies Using Multiple Genetic Variants. Int J Epidemiol (2011) 40(3):740–52. doi: 10.1093/ije/dyq151
    1. Burgess S, Butterworth A, Thompson SG. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data. Genet Epidemiol (2013) 37(7):658–65. doi: 10.1002/gepi.21758
    1. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian Randomization With Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol (2016) 40(4):304–14. doi: 10.1002/gepi.21965
    1. Bowden J, Davey Smith G, Burgess S. Mendelian Randomization With Invalid Instruments: Effect Estimation and Bias Detection Through Egger Regression. Int J Epidemiol (2015) 44(2):512–25. doi: 10.1093/ije/dyv080
    1. Maffeis C, Martina A, Corradi M, Quarella S, Nori N, Torriani S, et al. . Association Between Intestinal Permeability and Faecal Microbiota Composition in Italian Children With Beta Cell Autoimmunity at Risk for Type 1 Diabetes. Diabetes/Metabol Res Rev (2016) 32(7):700–9. doi: 10.1002/dmrr.2790
    1. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, et al. . Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes. PloS One (2011) (6):e25792. doi: 10.1371/journal.pone.0025792
    1. Nistal E, Caminero A, Vivas S, Ruiz de Morales JM, Sáenz de Miera LE, Rodríguez-Aparicio LB, et al. . Differences in Faecal Bacteria Populations and Faecal Bacteria Metabolism in Healthy Adults and Celiac Disease Patients. Biochimie (2012) 94(8):1724–9. doi: 10.1016/j.biochi.2012.03.025
    1. Pinto E, Anselmo M, Calha M, Bottrill A, Duarte I, Andrew PW, et al. . The Intestinal Proteome of Diabetic and Control Children Is Enriched With Different Microbial and Host Proteins. Microbiol (Read Engl) (2017) 163(2):161–74. doi: 10.1099/mic.0.000412
    1. Salamon D, Sroka-Oleksiak A, Kapusta P, Szopa M, Mrozińska S, Ludwig-Słomczyńska AH, et al. . Characteristics of Gut Microbiota in Adult Patients With Type 1 and Type 2 Diabetes Based on Next−Generation Sequencing of the 16S rRNA Gene Fragment. Polish Arch Intern Med (2018) 128(6):336–43. doi: 10.20452/pamw.4246
    1. Leiva-Gea I, Sánchez-Alcoholado L, Martín-Tejedor B, Castellano-Castillo D, Moreno-Indias I, Urda-Cardona A, et al. . Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study. Diabetes Care (2018) 41(11):2385–95. doi: 10.2337/dc18-0253
    1. Klemenak M, Dolinšek J, Langerholc T, Di Gioia D, Mičetić-Turk D. Administration of Bifidobacterium Breve Decreases the Production of TNF-α in Children With Celiac Disease. Digest Dis Sci (2015) 60(11):3386–92. doi: 10.1007/s10620-015-3769-7
    1. Smecuol E, Hwang HJ, Sugai E, Corso L, Cherñavsky AC, Bellavite FP, et al. . Exploratory, Randomized, Double-Blind, Placebo-Controlled Study on the Effects of Bifidobacterium Infantis Natren Life Start Strain Super Strain in Active Celiac Disease. J Clin Gastroenterol (2013) 47(2):139–47. doi: 10.1097/MCG.0b013e31827759ac
    1. Groele L, Szajewska H, Szalecki M, Świderska J, Wysocka-Mincewicz M, Ochocińska A, et al. . Lack of Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Lactis Bb12 on Beta-Cell Function in Children With Newly Diagnosed Type 1 Diabetes: A Randomised Controlled Trial. BMJ Open Diabetes Res Care (2021) 9(1):e001523. doi: 10.1136/bmjdrc-2020-001523
    1. López P, Gueimonde M, Margolles A, Suárez A. Distinct Bifidobacterium Strains Drive Different Immune Responses In Vitro . Int J Food Microbiol (2010) 138(1-2):157–65. doi: 10.1016/j.ijfoodmicro.2009.12.023

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner